Evidence map›Paper›PMID 35980034›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2022

Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease".

Adenrele M Gleason, Nahid Tayebi, Grisel J Lopez, Ellen Sidransky

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Adenrele M GleasonMedical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nahid TayebiMedical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Grisel J LopezMedical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Ellen SidranskyMedical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-3019-8500

Funding

Genetic and clinical studies of Gaucher disease and other lysosomal disordersZIAHG200336 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SIDRANSKY, ELLEN · 2009 to 2025
$45.2M
Intramural NIH HHS ZIA HG200336
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Parkinson Diseasealpha-SynucleinBiomarkersGlucosylceramidaseHumansMutationalpha-SynucleinBiomarkersGlucosylceramidase

Identifiers

PMID35980034
PMCPMC9756875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.